PARP1 and Parkinson disease: Other investigators have linked PARP1 hyperactivity to degenerative diseases such as diabetes, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism and injury induced brain disorders [1], [22], [55]–[58].